MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    FUS R521S mutation causing levodopa responsive amyotrophic lateral sclerosis-Parkinson’s disease (ALS-PD).

    R. Peh, EK. Tan, P. Kumar, MH. Yong, K. Narasimhalu (Singapore, Singapore)

    Objective: The coexistence of Parkinson's disease (PD) and ALS is uncommon. This overlap syndrome, characterized by levodopa-responsive parkinsonism in the context of ALS, has been…
  • 2026 International Congress

    Clinical progression of PSP-Richardson’s syndrome and other PSP variants in an East Asian cohort

    SM. Lee, R. Kim, JY. Lee (Seoul, Republic of Korea)

    Objective: This study aimed to compare longitudinal clinical progression between patients with progressive supranuclear palsy–Richardson syndrome (PSP-RS) and those with PSP-subcortical phenotypes. Background: PSP is…
  • 2026 International Congress

    Automated Identification of Freezing of Gait in Parkinson’s Disease Using Q-Learning Analysis during Virtual Reality–Based Gait Task

    K. Seo, M. Hara, S. Alaoui, T. Yamamoto, G. Oyama (Saitama, Japan)

    Objective: To investigate whether a virtual reality (VR)-based gait task can induce freezing of gait (FOG) in Parkinson’s disease (PD) and whether gait trajectory data…
  • 2026 International Congress

    Exploring a Milestone-Based Approach as an Outcome Measure for Disease-Modifying Parkinson Disease Trials

    C. Gonzalez-Robles, M. Burnell, A. Schrag, R. Weil, G. Mills, ML. Zeissler, J. Carpenter, S. Gandhi, C. Carroll, T. Foltynie (London, United Kingdom)

    Objective: To replicate a composite milestone(CM) approach in a range of Parkinson Disease(PD) studies(observational, clinical trials) over a long time period(up to 12 years). To…
  • 2026 International Congress

    The Diagnostic Value of Dopaminergic-Glucose United PET Imaging in Parkinson’s disease

    XY. Li, JY. Lu, FT. Liu, CT. Zuo, JW. Wang (Shanghai, China)

    Objective: This study aimed to evaluate the diagnostic efficacy of DAT-FDG united PET imaging in differentiating PD from other parkinsonian disorders in real-world clinical settings…
  • 2026 International Congress

    Cross-trait and Multi-polytranscriptomic Score Prediction of Parkinson’s Disease

    L. Gilchrist, O. Pain, S. Calhas, GP2. Genetics Program, A. Noyce, K. Brolin, T. Periñan, P. Proitsi (London, United Kingdom)

    Objective: To integrate genome-wide association study summary statistics, expression quantitative trait loci (eQTL), individual-level RNA sequencing data and machine-learning approaches to identify molecularly informed cross-trait…
  • 2026 International Congress

    Diffusion MRI Evidence of Cerebellar Involvement in Cognitive Dysfunction in Parkinson’s Disease

    A. Vijayakumari, L. Saadatpour, D. Floden, K. Sakaie, H. Kaur, H. Fernandez, B. Walter (Cleveland, USA)

    Objective: To determine whether cerebellar axonal microstructural abnormality is associated with cognitive performance in PD. Background: Cognitive impairment in Parkinson’s disease (PD) often affects executive…
  • 2026 International Congress

    Amyloid PET–Guided Anti-amyloid Therapy in Corticobasal Syndrome Associated with Clinical Improvement

    S. Fujioka, Y. Nagaishi, T. Imamura, H. Minagawa, K. Uwatoko, M. Yukitake, J. Kira, Y. Tsuboi (Chiba, Japan)

    Objective: To clarify the clinical significance of amyloid positron emission tomography (PET) in patients presenting with corticobasal syndrome (CBS) and to describe the potential therapeutic…
  • 2026 International Congress

    External Validation of a Machine Learning Classifier for Motor Progression in Parkinson’s Disease

    A. Vijayakumari, R. Popov, O. Hogue, H. Fernandez, B. Walter (Cleveland, USA)

    Objective: To externally validate a previously published machine learning (ML) classifier for predicting motor symptom progression in Parkinson’s disease (PD) using an independent clinical dataset.…
  • 2026 International Congress

    Cholinergic Pathway Degeneration Predicts Differential Phenoconversion to Synucleinopathies in Idiopathic REM Sleep Behavior Disorder

    D. Zhang, T. Wu (Beijing, China)

    Objective: This cross-sectional and longitudinal study aimed to elucidate the pattern of cholinergic white matter pathway degeneration underlying the phenoconversion trajectories in iRBD patients. Background:…
  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley